ANTIBODY-DRUG CONJUGATES
Clinical trials for ANTIBODY-DRUG CONJUGATES explained in plain language.
Never miss a new study
Get alerted when new ANTIBODY-DRUG CONJUGATES trials appear
Sign up with your email to follow new studies for ANTIBODY-DRUG CONJUGATES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy targets Hard-to-Treat salivary gland tumors
Disease control Not yet recruitingThis study tests a two-step treatment for people with salivary gland cancer that has come back or spread. First, patients get an antibody-drug conjugate (ADC) that delivers chemotherapy directly to cancer cells. If the disease stabilizes or only a few new spots appear, they also …
Matched conditions: ANTIBODY-DRUG CONJUGATES
Phase: PHASE2 • Sponsor: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University • Aim: Disease control
Last updated May 26, 2026 11:36 UTC
-
Promising drug offers hope for Hard-to-Treat ovarian cancer
Disease control Not yet recruitingThis study tests a drug called sacituzumab in 22 people with a rare and aggressive ovarian cancer (clear cell carcinoma) whose tumors grew after immunotherapy. The goal is to see if the drug can shrink tumors and control the disease. Participants will receive the drug and be moni…
Matched conditions: ANTIBODY-DRUG CONJUGATES
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated May 26, 2026 11:34 UTC
-
New hope for advanced colon cancer: drug duo targets tumors
Disease control Not yet recruitingThis study tests a new drug combination (SHR-1811 plus bevacizumab) as a second-line treatment for people with metastatic colorectal cancer that has worsened after initial therapy. About 80 adults aged 18-75 will participate to see if the combo shrinks tumors and delays cancer gr…
Matched conditions: ANTIBODY-DRUG CONJUGATES
Phase: PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated May 22, 2026 14:04 UTC